In addition, fluorescent probes that can stain Aβ deposits have gained increasing interest as potential tools for monitoring the progression of AD in vitro and in vivo. In principle, such fluorescent probes are advantageous over PET/SPECT methods, since they provide real-time, nonradioactive, and high-resolution imaging both in vivo and ex vivo. Figure 1 illustrates representative structures of such probes that, to-date, have found limited use as fluorescent labeling agents of Aβ deposits in small animal studies.
17À22 Reliable methods to fine-tune the optical and biocompatible properties of these amyloid-targeting agents and to improve their selectivity and affinity to amyloid deposits in tissue could further advance this optical strategy for AD monitoring and diagnosis. In general, an appropriate fluorescent probe for amyloids should have the following properties: 11, 18, 21 (a) molecular mass less than 600 Da, (b) emission wavelength above 450 nm to minimize background fluorescence from brain tissue 23 (c) high quantum yield, (d) appropriate lipophilicity (log P value between 1 and 3), (e) specificity to Aβ plaques, (f) sufficient binding affinity to aggregated amyloid peptides, (g) straightforward synthesis, and (h) upon binding to Aβ deposits, a significant change in fluorescent properties should be observed.
Recently, we reported the rational design of a new class of amyloid-binding agents based on the molecular rotor motif. 24, 25 This motif contains an electron-donor unit in conjugation with an electron acceptor and produces a fluorescence quantum yield that is dependent on the surrounding environment. Hindrance of the internal molecular rotation of the probe, by increasing the surrounding media rigidity or by reducing the available free volume needed for relaxation, leads to a decrease in the nonradiative decay rate and consequently an increase of fluorescent emission. Closer evaluation of the data led to the identification of 6-aminonapthalenyl-2-cyano-acrylate (ANCA) as a motif with potentially useful spectroscopic properties for fluorescent labeling of aggregated amyloids peptides (Figure 2) . Specifically, compound 6, referred to as ANCA-11, possesses a long emission wavelength and large increase in fluorescence intensity upon binding to Aβ fibrils. 24 In order to validate the ANCA scaffold as a general motif that can bind to aggregated Aβ peptides, we sought to examine whether structural changes at its periphery, including alterations at the water solubilizing groups or at the nitrogen substitution, can affect the binding and fluorescent properties of the probe. Herein, we present the synthesis and the optical properties of a small family of compounds based on the ANCA motif. The ex vivo staining of amyloid plaques in human tissue by these novel fluorescent probes is also presented.
A general strategy for the synthesis of all ANCA-based probes is depicted in Scheme 1. Commercially available methyl 6-bromonaphthalene-2-carboxylate (7) was converted to the corresponding naphthaldehyde 8 by reduction of the ester to the primary alcohol using DIBALH and oxidation of the resulting alcohol to the desired aldehyde upon treatment with PCC. 26 The transformation of the bromide to the appropriate amine demanded the use of novel chemistry to improve the yield and apply the method in bigger scale. To this end, treatment of bromide 8 in the presence of palladium using Buchwald and Hartwig conditions produced aldehydes 9À12 in excellent yield for most cases.
27À29 Kn€ ovenagel condensation of aldehydes 9À12 with the appropriate cyanoester 13 concluded the synthesis of the final probes 6 and 14À18, as a single stereoisomer (E isomer). 30 Deprotection of the acetal group of 18 using acidic resin yielded the final dye 19. Table 1 summarizes the R and X combinations of the final products and the condensation yields. Based on their chemical structures, the synthesized probes can be separated in two subgroups: compounds 6, 17, and 19 (group A) that contain an identical piperidine donor group and differ only in the water solubilizing group (WSG) area (triethylene glycol monomethyl ether, tetraethylene glycol monomethyl ether, and propane 1,2-diol motif, respectively), and compounds 6, 14, 15, and 16 (group B) that contain an identical WSG motif (triethylene glycol monomethyl ether) but differ in the nitrogen substitution. To be useful, a fluorescent amyloid-binding probe should display a significant increase in fluorescence emission upon binding with the aggregates as compared to the emission of the free probe in solution. 31 To test whether the ANCA family of probes possessed these desirable fluorescence properties, we compared the fluorescent properties of all free probes in aqueous solution to their fluorescence properties in the presence of aggregated Aβ42 peptides. We chose to evaluate the binding of probes to Aβ42 instead of Aβ40, since Aβ42 is the major amyloid species found in AD plaques.
2,32À34 Specifically, we evaluated the fluorescent properties of each probe at a final concentration of 4 μM in nanopure water, before and after mixing with aggregated Aβ42 peptide (final concentration peptide = 5 μM). As shown in Table 2 , in all cases, we observed a significant increase (2.9À8.4-fold) in the intensity of the emission spectra of the probes upon association with the aggregated amyloid peptides. 35 This intensity increase was also accompanied by a blue shift in the emission spectra of around 5À50 nm. After binding, all compounds had excitation maxima between 380 and 430 nm and their emission maxima were between 525 and 550 nm, suggesting that small changes in the donor or acceptor part of the molecule do not alter significantly their fluorescent maxima. However, compounds 6, 17, and 19 (group A), that possess piperidine as the electron donor, showed higher increase in fluorescence intensity after binding (7.7-, 8.4-, and 6.6-fold, respectively) as compared to probes containing piperazine (14) , morpholine (15) , or morpholino-ethanamine (16) groups as electron donors (group B). Figure 3 provides a representative example of the fluorescent properties of compound 14.
We also measured the apparent binding constants (K d ) of the probes to aggregated Aβ42 peptides. The fluorescent intensity of each probe was measured at concentrations of 1.25, 2.5, 5.0, and 10 μM in nanopure water, mixed with preaggregated Aβ42 peptides (final concentration of peptide = 5 μM). 36 In all cases, the K d values were between 1.4 and 13.8 μM. Interestingly, group A exhibited the highest affinity to aggregated Aβ peptides. The nearly identical K d values obtained for these dyes (1.4À1.6 μM) indicate that small chemical modifications within the watersolubilizing region of the ANCA motif do not affect significantly the binding of the probes to Aβ aggregates. On the other hand, a measurable change of the K d value was observed upon chemically altering the electron donor moiety of the ANCA motif. As shown in Table 2 , compounds having piperidine as the electron donor were found to have lower K d values (1.4À1.6 μM) compared to those possessing piperazine, morpholine, or morpholinoethanamine as electron donor (compounds 14, 15, and 16 respectively).
Finally, the lipophilicity (log P) of the synthesized probes was calculated. 37 All compounds were found to have log P values between 2.5 and 3.8, suggesting that most of them possess the desirable properties for biocompatibility and can potentially cross the blood brain barrier. 38 In order to assess whether this family of ANCA-based fluorescent probes could stain amyloid deposits in brain tissue, we exposed sections of frozen human brain tissue (derived from the cerebral cortex of AD cases) to solutions containing the fluorescent probes. Figure 4 shows representative examples of fluorescence micrographs of these tissue samples incubated with each probe. As can be seen in Figure 4 , all tissue samples exposed to the ANCA probes contained small regions within the tissue that exhibited a significant concentration of fluorescence. As a negative control, we exposed frozen tissue sections to control vehicle (DMSO/PBS buffer) and did not observe such concentrated areas of fluorescence (data not shown). More interestingly, inspection of the images from these staining experiments (Figure 4 ) reveals a trend of increased fluorescent labeling of amyloid plaques using probes 14 and 15 compared to all other probes ( Figure 4G ). This trend can be seen by increased fluorescence contrast between the plaques and surrounding tissue in Figure 4B , C (corresponding to tissue samples stained with compounds 14 and 15) compared to the weaker observed contrast between the plaques and the surrounding tissue shown in Figure 4A , DÀF (corresponding to tissue samples stained with compounds 6, 16, 17, and 19). We hypothesize that the improved contrast of amyloid deposits stained with probes 14 and 15 may be attributed to their increased hydrophilicity compared to 6, 16, 17, and 19. The increased hydrophilic properties of 14 and 15 could reduce the amount of nonspecific staining by these probes to the brain tissue. This effect would result in the observed trend for increased fluorescence contrast between the plaques and surrounding tissue when using the more hydrophilic fluorescent probes.
In addition, Figure 5AÀC shows representative fluorescence micrographs of a single formalin-fixed tissue sample from a human AD patient that was treated sequentially with a mouse monoclonal anti-human Aβ IgG (clone 82E1), a fluorescently labeled polyclonal anti-mouse IgG, and a solution containing probe 15. The bright green areas in Figure 5A indicate the regions of tissue that are labeled by compound 15, the bright red areas in Figure 5B indicate the regions of the tissue that are labeled by the anti-Aβ IgGs, and the bright yellow areas in Figure 5C represent the regions where probe 15 and the anti-Aβ IgGs overlap in the tissue. The images in Figure 5AÀC reveal that the fluorescent ANCA probes label the amyloid deposits with good specificity in these human tissue sections. These staining experiments strongly support the notion that the ANCA-based probes are capable of marking the location of amyloid deposits within human brain tissue.
In conclusion, we show that the amino naphthalenyl-2-cyanoacrylate (ANCA) motif has appropriate fluorescence characteristics for the targeting and staining of Aβ deposits in tissue. Functionalization of this motif with water solubilizing groups does not affect the binding to Aβ but can help with the biocompatibility and water-solublizing properties of the compounds. 37, 39 On Fluorescence Studies with Aggregated Aβ Peptides. Aggregated Aβ peptide was prepared as described previously. 24 Briefly, we dissolved Aβ42 in PBS pH 7.4 to a final concentration of 100 μM. This solution was magnetically stirred at 1200 rpm for 3 days at room temperature. Aliquots of 15 μL of the preaggregated Aβ42 solution were added to 285 μL of the probe (5% DMSO in nanopure water) to attain a final concentration of 5 μM Aβ(1À42) and 4 μM of the probe. The solution was transferred to a 300 μL cuvette, and the fluorescence was measured.
Determination of Binding Constant. Preaggregated Aβ42 (5 μM final concentration) was mixed with various concentrations of probes (10, 5, 2.5, 1.25 μM) in 5% DMSO in nanopure water, and their K d 's were determined as described previously. Staining of Human Tissue Sections. Frozen brain sections from patients diagnosed with AD were dried for 1 h, treated with 100%, 95%, and 70% ethanol for 5 min each, and then rinsed in deionized water. The sections were equilibrated in phosphate-buffered saline (PBS) for 15 min. Fluorescent molecules were diluted in PBS (1:50, from stock solutions of 3 mM in PBS to give a final concentration of 60 μM), added to the brain sections, incubated for 30 min at room temperature, washed with PBS, and coverslipped.
Costaining with the Aβ Antibody 82E1 and Compound 15. Aβ and compound 15 costaining was performed on a formalin-fixed brain section from an AD case. Slides were deparaffinized, incubated for 5 min in 98% formic acid, and then washed in distilled water for 5 min. Sections were blocked with 10% goat serum and incubated with anti-Aβ antibody 82E1 (Immunobiological Laboratories) for 30 min. The slides were washed with PBS containing 0.2% tween and stained with antibody anti-mouse HRP (Jackson Immunolabs), washed in PBS-tween, and tyramide-Alexa Fluor 594 (Invitrogen) for 30 min. After washing with PBS-tween, the slides were stained with 60 μM solutions of compound 15 for 30 min. Control sections were costained with the mouse isotype control antibody as the primary antibody, and the PBS control buffer that was used to generate stock solutions of compound 15. Adjacent sections were singly stained with Aβ antibody 82E1 or compound 15.
Fluorescence Microscopy. The sample was excited using an argon 488 nm laser on an Olympus FluoView FV1000 confocal microscope. The emission spectra of the probes bound to Aβ or background were collected in 5 nm increments from 450À645 nm. A minimum of 10 measurements were collected for probe bound to Aβ and for background. The peak intensity for the Aβ-bound probe was divided by an average of the background measurements to calculate the ratio of probe to background signal. 
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